- 全部删除
您的购物车当前为空
CM-579 trihydrochloride is a first-in-class reversible and dual inhibitor of G9a and DNMT (IC50s: 16 nM, 32 nM) with potent in vitro cellular activity in a wide range of cancer cells.

CM-579 trihydrochloride is a first-in-class reversible and dual inhibitor of G9a and DNMT (IC50s: 16 nM, 32 nM) with potent in vitro cellular activity in a wide range of cancer cells.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 8-10周 | |
| 50 mg | ¥ 13,800 | 8-10周 | |
| 100 mg | ¥ 17,500 | 8-10周 |
CM-579 trihydrochloride (1846570-40-8 free base) 相关产品
| 产品描述 | CM-579 trihydrochloride is a first-in-class reversible and dual inhibitor of G9a and DNMT (IC50s: 16 nM, 32 nM) with potent in vitro cellular activity in a wide range of cancer cells. |
| 靶点活性 | G9a:16 nM, DNMT3A:92 nM, DNA methyltransferase:32 nM, DNMT1:1.5 nM (kd), DNMT3B:1000 nM |
| 体外活性 | The Kd of CM-579 for DNMT1 is 1.5 nM, CM-579 also inhibits DNMT3A and DNMT3B (IC50s: 92 nM and 1000 nM). |
| 别名 | CM-579 trihydrochloride |
| 分子量 | 602.04 |
| 分子式 | C29H43Cl3N4O3 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: 37.5 mg/mL (62.29 mM), Sonication is recommended. DMSO: 125 mg/mL (207.63 mM), Sonication is recommended. MEthanol: 75 mg/mL (124.58 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
H2O/MEthanol/DMSO
MEthanol/DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容